FDA Drug Application (020044) for EXOSURF NEONATAL by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number020044
Product Number001
FormFOR SUSPENSION;INTRATRACHEAL
Dosage12MG/VIAL;108MG/VIAL;8MG/VIAL
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEXOSURF NEONATAL
Active IngredientCETYL ALCOHOL; COLFOSCERIL PALMITATE; TYLOXAPOL



Back to FDA Applications sponsored by GLAXOSMITHKLINE